Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CELZ — Creative Medical Technology Holdings, Inc.

CIK 1214717 BOSTON, MA
Back to CELZ Full portfolio

Position in CELZ

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$37,408
-$41,468 QoQ
Shares Held
25,799
-32.6% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 15 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CELZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. CELZ ranks #485 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CELZ

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,408 25,799
2026-03-31 $78,876 38,290
2025-12-31 $55,794 28,467
2025-09-30 $77,442 23,256
2025-06-30 $55,320 20,876
2025-03-31 $39,641 18,268
2024-12-31 $23,810 10,308
2023-03-31 $62,112 124,224
2022-12-31 $13,086 34,338
2022-09-30 $15,108 34,338
2022-06-30 $25,753 34,338